Study: Zofran May Double Risk Of Heart Defects In A Fetus

Use of the anti-nausea drug Zofran to treat morning sickness during pregnancy could heighten the risk that a fetus will suffer from birth defects, according to a literature review of existing research. Birth defects allegedly associated with the drug include heart defects and other congenital malformations. Affected families are pursuing claims against drug maker GlaxoSmithKline with the assistance of New York birth injury lawyers.

If you or a loved one took Zofran during pregnancy and delivered a child with birth defects or other complications, contact Attorney Group for New York for more information. We provide free, confidential, no obligation consultations. We can help answer your questions, and if you choose to pursue a claim we can connect you with an affiliated Zofran lawsuit attorney who can assist you throughout the legal process.

The time you have to pursue a claim is limited. Contact us for more information.Get Help Now.

Study Suggests Zofran May Also Increase The Risk Of Malformations

A literature review published in 2014 in The American Journal of Obstetrics & Gynecology, indicates that the risk of birth defects associated with anti-nausea drug Zofran, may be significant. According to the article, the drug, which is often used to treat morning sickness, could raise the risk of malformations of a fetus’s heart and other body parts, particularly when used during the first ten weeks of pregnancy.

Research into the effects of Zofran on fetal development has yielded mixed results. However, the review cites one study that found babies were 30 percent more likely to suffer from congenital malformations if their mothers took Zofran during pregnancy. Use of Zofran also allegedly doubled the risk of heart defects, according to the same study.

Zofran is not approved by the U.S. Food and Drug Administration (FDA) for use during pregnancy, but in 2013, over 110,000 monthly prescriptions for this drug were issued to women suffering from morning sickness. The review notes that in 2013, the FDA did approve another drug for the treatment of nausea and vomiting during pregnancy.

Affected Families May Be Entitled to Compensation

Drug manufacturers have a duty to ensure their products are accompanied by full and accurate instructions and warnings to guide prescribing doctors and other health care providers in making treatment decisions. If a drug maker fails to fulfill this duty, it could be held liable in lawsuits for injuries that may result.

The parents of children who were born with birth defects linked to Zofran may be entitled to compensation for damages, including the child’s:

  • Medical expenses
  • Pain, suffering, and mental anguish
  • Scarring or physical deformities caused by the birth defect or treatment

If a child died due to birth defects linked to Zofran, family members may be entitled to compensation for the wrongful death of their loved one, including:

  • Conscious pain and suffering of their child prior to death
  • Pain, suffering, and mental anguish from the loss of a child
  • Funeral expenses

Affected families are encouraged to seek the advice of a Zofran lawsuit attorney to learn more about their rights and remedies.

Contact Us For More Information

For more information, contact Attorney Group for New York. You can fill out the form on this page, call us at the number listed at the top of the page, or email us at [email protected].

When you contact us, an attorney will follow up with you to speak with you about your case or answer questions that you might have. There is no cost or obligation to speak with us, and any information you provide will be kept confidential.

Please note that the law limits the time you have to pursue a claim or file a lawsuit for an injury. If you think you have a case, you should not delay taking action.

See our Frequently Asked Questions page for more information, and contact Attorney Group for New York today.

Comments